» Articles » PMID: 33997317

Downregulation of MiR-21 Gene Expression by CRE-Ter to Modulate Osteoclastogenesis: De Novo Mechanism

Overview
Specialty Biochemistry
Date 2021 May 17
PMID 33997317
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

miR-21 expression stimulates osteoclast cells in the context of osteoclastogenesis. A previous report showed that NFκB-miR-21 pathway could serve as an innovative alternative to devise therapeutics for healing diabetic ulcers. Furthermore, our study demonstrated that a highly water-soluble curcuminoids-rich extract (CRE-Ter) inhibits osteoclastogenesis through NFκB pathway. The interplay between miR-21 and CRE-Ter in osteoclastogenesis has not yet been investigated. In this study, we examined the relation of CRE-Ter and miR-21 gene expression in receptor of the nuclear factor κB (NFκB) ligand (RANKL) - induced murine monocyte/macrophage RAW 264.7 cells, osteoclast cells, in osteoclastogenesis. Effect of CRE-Ter on generation of intracellular reactive oxygen species (ROS) was estimated by dichlorofluorescein diacetate (DCFH-DA). The results reveal that CRE-Ter reduced expression levels of miR-21 gene in osteoclasts. The inhibitory effects of CRE-Ter on osteoclastogenesis were evaluated by reduction in tartrate-resistant acid phosphatase (TRAP) content, and by reduction in expression levels of an osteoclast-specific gene, cathepsin K. Treatment of the osteoclast cells with CRE-Ter suppressed RANKL-induced NFκB activation including phospho-NFκB-p65, and phospho IκBα proteins. Western blot analysis revealed that NFκB inhibitor up-regulated CRE-Ter-promoted expression of phospho-NFκB-p65. In addition, CRE-Ter dose-dependently inhibited phospho-Akt expression. CRE-Ter also dose-dependently reduced DNA binding activity of NFκB and Akt as revealed by EMSA. ChIP assay revealed binding of NFκB-p65 to miR-21 promoters. In conclusion, our results demonstrate that CRE-Ter downregulates miR-21 gene expression in osteoclasts via a de novo mechanism, NFκB- Akt-miR-21 pathway.

Citing Articles

Curcuminoids-enriched extract and its cyclodextrin inclusion complexes ameliorates arthritis in complete Freund's adjuvant-induced arthritic mice via modulation of inflammatory biomarkers and suppression of oxidative stress markers.

Saleem U, Chauhdary Z, Bakhtawar Z, Alqahtani J, Farrukh M, Alsharif I Inflammopharmacology. 2023; 31(6):3047-3062.

PMID: 37955785 DOI: 10.1007/s10787-023-01370-2.


Modified Curcuminoid-Rich Extract Liposomal CRE-SDInhibits Osteoclastogenesis via the Canonical NF-κB Signaling Pathway.

Jantarawong S, Swangphon P, Lauterbach N, Panichayupakaranant P, Pengjam Y Pharmaceutics. 2023; 15(9).

PMID: 37765217 PMC: 10537735. DOI: 10.3390/pharmaceutics15092248.

References
1.
Darnay B, Haridas V, Ni J, Moore P, Aggarwal B . Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem. 1998; 273(32):20551-5. DOI: 10.1074/jbc.273.32.20551. View

2.
Gamez B, Rodriguez-Carballo E, Ventura F . MicroRNAs and post-transcriptional regulation of skeletal development. J Mol Endocrinol. 2014; 52(3):R179-97. DOI: 10.1530/JME-13-0294. View

3.
Xie L, Li X, Takahara S . Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol. 2010; 11(3):323-30. DOI: 10.1016/j.intimp.2010.08.013. View

4.
Li Y, Jiang Z, Chen H, Ma W . A modified quantitative EMSA and its application in the study of RNA--protein interactions. J Biochem Biophys Methods. 2004; 60(2):85-96. DOI: 10.1016/j.jbbm.2004.03.008. View

5.
Ammon H, Wahl M . Pharmacology of Curcuma longa. Planta Med. 1991; 57(1):1-7. DOI: 10.1055/s-2006-960004. View